?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
November 5, 2015
Katie Quinn
EPIRUS Biopharmaceuticals Joins Biosimilars Forum to Help Educate Patients and Health Care Providers on Importance of Biosimilars
News
October 30, 2015
Katie Quinn
Biosimilars Forum Disappointed with CMS Final Rule on Biosimilar Payment and Coding
News
October 27, 2015
Katie Quinn
Biosimilars Forum Comments on FDA Naming Guidance
News
October 8, 2015
Katie Quinn
Biosimilars Forum Applauds Senators Roberts, Carper for Leadership on Proposed Medicare Rule on Biosimilar Coding
News
September 8, 2015
Katie Quinn
Biosimilars Forum Issues Comments for CMS Proposed Rule on Biosimilar Payment and Coding
News
September 3, 2015
Katie Quinn
Biosimilars Forum Statement on the Introduction of Biosimilars in the United States
News
August 27, 2015
Katie Quinn
Forum Statement on Proposed FDA Guidance on Naming of Biological Products
News
August 5, 2015
Katie Quinn
Biosimilars Forum Applauds Reps. Barton, Eshoo for Leadership on Proposed Medicare Rule on Biosimilar Coding
News
July 9, 2015
Katie Quinn
Biosimilars Forum Expresses Concern with CMS Proposed Rule on Biosimilar Payment and Coding
News
May 5, 2015
Katie Quinn
Biosimilars Forum Statement Regarding the Need for Appropriate Coding for Biosimilars
Prev page
17
18
19
20
Next page